CNC vs RAPT · P/E 8.4, rev $103.52B vs $132.1M cap
Centene Corp (CNC) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the CNC and RAPT stock pages for the full models.
Not investment advice.